Home » New Zealand, EU Sign Accord on GMP Inspections, Conformity Assessments
New Zealand, EU Sign Accord on GMP Inspections, Conformity Assessments
January 10, 2013
Drugmakers doing business in both the EU and New Zealand will face fewer conformity assessment reviews and quality assurance inspections, thanks to a mutual recognition agreement between regulators in the two jurisdictions.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor